WARRINGTON, Pa., Aug. 3, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to improving the standard of respiratory critical care through its KL4 surfactant and aerosol drug delivery technologies, today reports financial results for the second quarter ended June 30, 2011 and provides an update on lead pipeline programs. The Company will host a conference call this morning at 10:00 AM EDT. Conference call details are below.
